Increased amyloidogenic processing of transgenic human APP in X11-like deficient mouse brain

Molecular Neurodegeneration

Volumn 5, Issue 1, 2010, Pages

  Kondo, Maho ^a   Shiono, Maki ^a   Itoh, Genzo ^b   Takei, Norio ^a,b   Matsushima, Takahide ^a   Maeda, Masahiro ^b   Taru, Hidenori ^a   Hata, Saori ^a   Yamamoto, Tohru ^a   Saito, Yuhki ^a   Suzuki, Toshiharu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Immuno Biological Laboratories Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BINDING PROTEIN; PROTEIN X 11; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN METABOLISM; PROTEIN TARGETING; REGULATORY MECHANISM;

MUS MUSCULUS;

EID: 77956525555     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-5-35     Document Type: Article

References (27)

1. Interaction of a neuron-specific protein containing PDZ domains with Alzheimer's amyloid precursor protein. S Tomita T Ozaki H Taru S Oguchi S Takeda Y Yagi S Sakiyama Y Kirino T Suzuki, J Biol Chem 1999 274 2243 2254 10.1074/jbc.274.4.2243 9890987
2. Expression and characterization of the Drosophila X11-like/Mint protein during neural development. M Hase Y Yagi S Tomita A Sumioka K Hori K Miyamoto T Sasamura M Nakamura K Matsuno T Suzuki, J Neurochem 2002 81 1223 1232 10.1046/j.1471-4159.2002.00911.x 12068070
3. The adaptor protein X11Lalpha/Dmint1 interacts with the PDZ-binding domain of the cell recognition protein Rst in Drosophila. S Vishnu A Hertenstein J Betschinger JA Knoblich H Gert de Couet KF Fishbach, Dev Biol 2006 289 296 307 10.1016/j.ydbio.2005.09.016 16380111
4. Generation and maintenance of neural polarity mechanisms of transport and targeting. D Foletti R Prekeris RH Scheller, Neuron 1999 23 641 644 10.1016/S0896-6273(01)80022-2 10482230
5. The X11 proteins, Abeta production and Alzheimer's disease. CC Miller DM McLoughlin KF Lau ME Tennant B Rogelj, Trends Neurosci 2006 29 280 285 10.1016/j.tins.2006.03.001 16545469
6. The X11alpha protein slows cellular amyloid precursor protein processing and reduces A40 and A42 secretion. JP Borg Y Yang M De Taddeo-Borg B Margolis RS Turner, J Biol Chem 1998 273 14761 14766 10.1074/jbc.273.24.14761 9614075
7. X11L2, a new member of the X11 protein family, interacts with Alzheimer's -amyloid precursor protein. H Tanahashi T Tabira, Biochem Biophys Res Commun 1999 255 663 667 10.1006/bbrc.1999.0265 10049767
8. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid -peptide. C Haass DJ Selkoe, Nat Rev Moll Cell Biol 2007 2 101 112 10.1038/nrm2101 (Pubitemid 46432529)
9. Amyloid precursor protein trafficking, processing, and function. G Thinakaran E Koo, J Biol Chem 2008 283 29615 29619 10.1074/jbc.R800019200 18650430
10. Enhanced amyloidogenic metabolism of the amyloid -protein precursor in the X11L-deficient mouse brain. Y Sano A Syuzo-Takabatake T Nakaya Y Saito S Tomita S Itohara T Suzuki, J Biol Chem 2006 281 37853 37860 10.1074/jbc. M609312200 17032642
11. X11 proteins regulate the translocation of amyloid -protein precursor (APP) into detergent-resistant membrane and suppress the amyloidogenic cleavage of APP by -site-cleaving enzyme in brain. Y Saito Y Sano R Vassar S Gandy T Nakaya T Yamamoto T Suzuki, J Biol Chem 2008 283 35763 35771 10.1074/jbc.M801353200 18845544
12. Regulation of amyloid -protein precursor by phosphorylation and protein interactions. T Suzuki T Nakaya, J Biol Chem 2008 283 29633 29637 10.1074/jbc.R800003200 18650433
13. Exclusively targeting -secretase to lipid rafts by GPI-anchor addition up-regulates -site processing of the amyloid precursor protein. JM Cordy I Hussain C Dingwall M Hooper AJ Turner, Proc Natl Acad Sci USA 2003 100 11735 11740 10.1073/pnas.1635130100 14504402
14. Amyloidogenic processing of the Alzheimer -amyloid precursor protein depends on lipid rafts. R Ehehalt P Keller C Haass C Thiele K Simons, J Cell Biol 2003 160 113 123 10.1083/jcb.200207113 12515826
15. The neuronal adaptor protein X11 reduces A levels in the brains of Alzheimer's APPswe Tg2576 transgenic mice. JH Lee KF Lau MS Perkinton CL Standen SJ Shemilt L Mercken JD Cooper DM McLoughlin CC Miller, J Biol Chem 2003 278 47025 47029 10.1074/jbc.M300503200 12970358
16. The neuronal adaptor protein X11 reduces amyloid -protein levels and amyloid plaque formation in the brains of transgenic mice. JH Lee KF Lau MS Perkinton CL Standen B Rogelj A Falinska DM McLoughlin CC Miller, J Biol Chem 2004 279 49099 49104 10.1074/jbc.M405602200 15347685
17. Deletion of Mint proteins decreases amyloid production in transgenic mouse models of Alzheimer's disease. A Ho X Liu TC Sudhof, J Neurosci 2008 28 14392 14400 10.1523/JNEUROSCI.2481-08.2008 19118172
18. Mutation of the -amyloid precursor protein in familial Alzheimer's disease -protein production. M Citron T Oltesdorf C Haass L McConlogue AY Hung Seubert C Vigo-Pelfrey I Lieberburg DJ Selkoe, Nature 1992 360 672 674 10.1038/360672a0 1465129
19. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. C Struchler-Pierrat D Abramowski M Duke KH Wiedehold C Mistl S Rothacher B Ledemann K Burki P Frey PA Paganetti C Waridel ME Calhoun M Jucker A Probst M Staufenbiel B Sommer, Proc Natl Acad Sci USA 1997 94 13287 13292 10.1073/pnas.94.24.13287 9371838
20. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. DR Borchelt T Ratovitski J van Lare MK Lee V Gonzales NA Jenkins NG Copeland DL Price SS Sisodia, Neuron 1997 19 939 945 10.1016/S0896-6273(00)80974-5 9354339
21. Amyloid- protein dimers isolated directly from Alzheimer's brain impair synaptic plasticity and memory. GM Shankar S Li TH Methta A Garcia-Munoz NE Shepardson I Smith FM Brett MA Farrell MJ Rowan CA Lemere CM Regan DM Walsh BL Sabatini DJ Selkoe, Nat Med 2008 14 837 842 10.1038/nm1782 18568035
22. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. A Rovelet-Leurux D Hannequin G Raux N Le Meur A Laquerriere A Vital C Dumanchin S Feuillette A Brice M Vercelletto F Dubas T Frebourg D Campion, Nat Genet 2006 38 24 26 10.1038/ng1718 16369530
23. X11 haploinsufficiency enhances A amyloid deposition in Alzheimer's disease transgenic mice. I Saluja H Paulson A Gupta SR Turner, Neurobiol Dis 2009 36 162 168 10.1016/j.nbd.2009.07.006 19631749
24. X11 rescues memory and long-term protention deficitis in Alzheimer's disease APPswe Tg2576 mice. JC Michell BB Ariff DM Yates KF Lau MS Perkinton B Rogelj JD Stephenson CCJ Miller DM McLoughlin, Human Mol Gennet 2009 18 4492 4500 10.1093/hmg/ddp408
25. Pathological and physiological functions of presenilins. KS Vetrivel Y-w Zhang H Xu G Thinakaran, Mol Neurodegen 2006 1 4 10.1186/1750-1326-1-4 (Pubitemid 46724554)
26. Cleavage of Alzheimer's amyloid precursor protein (APP) by secretases occurs after O-glycosilation of APP in the protein secretory pathway. S Tomita Y Kirino T Suzuki, J Biol Chem 1998 273 6277 6284 10.1074/jbc.273.11.6277 9497354
27. Role of APP phosphorylation in FE65-dependent gene transactivation mediated by AICD. T Nakaya T Suzuki, Genes Cell 2006 11 633 645 10.1111/j.1365-2443.2006.00968.x (Pubitemid 43744814)